Amalgamated Bank’s Alpine Immune Sciences Inc ALPN Stock Holding History

Amalgamated Bank’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,298	Closed	-$51K	–	3166
2024 Q1	$51K	Sell	1,298 -2,399	-65%	-$70.8K	﹤0.01%	1868
2023 Q4	$70K	Buy	3,697 +41	+1%	+$570	﹤0.01%	2119
2023 Q3	$42K	Hold	3,656	–	–	﹤0.01%	2328
2023 Q2	$38K	Buy	3,656 +823	+29%	+$7.42K	﹤0.01%	2439
2023 Q1	$22K	Buy	2,833 +448	+19%	+$3.57K	﹤0.01%	2619
2022 Q4	$18K	Buy	2,385 +355	+17%	+$2.27K	﹤0.01%	2780
2022 Q3	$15K	Buy	2,030 +16	+0.8%	+$132	﹤0.01%	2886
2022 Q2	$17K	Buy	2,014 +123	+7%	+$1.06K	﹤0.01%	2899
2022 Q1	$17K	Buy	+1,891	New	+$16.4K	﹤0.01%	2853

Amalgamated Bank's ALPN Position: Q2 2024 in Review

Amalgamated Bank sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,298 shares — an estimated $51K sold.

Amalgamated Bank first reported a position in ALPN in Q1 2022 and held it in 9 quarters. The position peaked at $70K in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Amalgamated Bank reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Amalgamated Bank sold 1,298 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $51K.
Amalgamated Bank first reported a position in Alpine Immune Sciences Inc in Q1 2022 and held it in 9 quarters.
Amalgamated Bank's Alpine Immune Sciences Inc position peaked at $70K in Q4 2023.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.